Previously, we have shown that pyruvate kinase, liver and red cell isoform (PKLR) deficiency protects mice in vivo against blood-stage malaria, and observed that reduced PKLR function protects human erythrocytes against Plasmodium falciparum replication ex vivo. Here, we have sequenced the human PKLR gene in 387 individuals from malaria-endemic and other regions in order to assess genetic variability in different geographical regions and ethnic groups. Rich genetic diversity was detected in PKLR, including 59 single-nucleotide polymorphisms and several loss-of-function variants (frequency 1.5%). Haplotype distribution and allele frequency varied considerably with geography. Neutrality testing suggested positive selection of the genein the sub-Saharan African and Pakistan populations. It is possible that such positive selection involves the malarial parasite.
Introduction
Erythrocytes rely exclusively on glycolysis for production of adenosine triphosphate, and, therefore, loss of pyruvate kinase, liver and red cell isoform (PKLR) activity has major consequences for cell function and lifespan. PK deficiency is the second most common cause of hereditary nonspherocytic hemolytic anemia in humans. 1 The large mutational spectrum in PKLR is associated with a broad clinical spectrum, varying from mild anemia to a transfusiondependent disorder. 2, 3 Clinical PK deficiency is usually associated with homozygosity or compound heterozygosity of mutant alleles. 3 PK-deficiency protects mice against blood-stage malaria (Plasmodium chabaudi) in vivo; 4 and studies with P. falciparum-infected erythrocytes demonstrate both homozygosity and heterozygosity for mutant PKLR alleles decrease parasite invasion and replication, and increase phagocytosis of infected cells. 5, 6 These findings raise the possibility that human PKLR variants may have a protective effect if retained in malaria-pressured areas. To address this possibility, we sequenced the PKLR gene from 387 individuals, primarily those of African and Asian origin living in malaria-endemic areas (Figure 1a ).
Results and discussion
Sequencing PKLR identified 59 polymorphic sites, including 30 previously unreported single-nucleotide polymorphisms (SNPs; Figure 1b , Supplementary Table 1 for details). Full nucleotide sequences can be found by accessing the CEPH database. Our data is almost certainly an underestimate as the sequencing technology failed to accurately read through two highly repetitive AT-rich regions of the gene. 7 The majority of SNPs were in non-coding regions, though seven synonymous coding SNPs (A36A, Q57Q, L61L, R194R, L236L, L301L and R569R) and seven non-synonymous mutations were detected ( Figure 2 ). Many SNPs (21/59) were limited to a single heterozygote individual. The sub-Saharan population (SS) showed the highest diversity with 31 polymorphisms, including 13 unique sites (Figure 1b;  Supplementary Table 2 ). The European (EUR) dataset had the lowest genetic diversity (eight SNPs), though only a small number of individuals were included (n ¼ 23). All SNPs were in Hardy-Weinberg equilibrium within the populations in which they were detected with the exception of rs3762272 in Pakistan (PAK), which had an excess of minor allele homozygotes (Po0.0002). Most of these were Hazara, likely indicating population substructure in the PAK group. This SNP was also enriched in PAK (minor allele frequency, MAF PAK ¼ 11.6%) and Southeast Asia (SEA, MAF SEA ¼ 19.6%) while being nearly absent in Africa.
We observed linkage disequilibrium across the entire gene in all but the EUR population. To compare haplotype distribution between populations, we used the seven SNPs indicated by arrows in Figure 1b , which assigned 490% of samples to a haplotype with a frequency 42% (Figure 1c) . Two haplotypes dominated: 5 0 -TTGGCCT-3 0 (haplotype 1), which accounts for the majority of samples in North Africa (NA), PAK, SEA and EUR, and matches the UCSC reference genome-and 5 0 -CCCGATC-3 0 (haplotype 2), which accounts for the majority of SS and South African (SA) haplotypes. The ancestral haplotype 7 was represented at 10.4% frequency in SS, but below 5% in other populations. All populations had significantly different haplotype distributions (w 2 -test, Po0.05). The seven non-synonymous PKLR coding mutations suggest an overall mutant allele frequency of 1.5 ± 0.9% ( Figure 2 ). All mutations were found as heterozygotes, and no one had more than one mutation present. Pakistan had the highest mutation diversity with V269F (Hazara), L272V (Balochi), R449C (Makrani), E277K (Brahui) and R486W (Burusho) appearing as singletons. When the data were phased using BEAGLE software, 8 all of the PAK SNPs except E277K appeared on haplotype 1, which was the most frequently observed haplotype in this population. R486W in NA appeared on the same haplotype. E277K appeared in a Brahui (PAK) individual on haplotype 7 and on a rare haplotype (5 0 -CCGGACT-3 0 , o2%) in a Mandenka individual (SS), having likely arisen separately. The A295I mutation in a Biaka Pygmy appeared on the most common haplotype in SS (haplotype 2). All of these mutations are too rare to have influenced the underlying haplotype distribution, when we examined the extended haplotype homozygosity using Sweep 9 (data not shown). In the NA dataset, A31V appeared in four individuals (MAF NA ¼ 6.9%), three times on haplotype 2 (27% frequency) and a fourth time on haplotype 5 that differs by a single T/C polymorphism at the distal end of the haplotype block. This polymorphism may have appeared recently on a common core haplotype within the Mozabite lineage, and been retained at a moderate frequency either by positive selection or by relatedness within the population (Supplementary Figure 1) . Although the mutated individuals are not first-or second-degree relatives, 10 CEPH panel Mozabites have a high inbreeding coefficient 11 and historically small effective population size. 12 Recent common ancestry or ascertainment bias inherent to the small sample size may be confounding variables.
To examine more closely the potential functional consequences of the mutations, we compared the PKLR protein across 13 species (Homo sapiens NP_000289. [9]
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Figure 1 Rattus norvegicus NP_036756.3, Oryctolagus cuniculus XP_002715467.1, Monodelphis domestica XP_001374169.1, Gallus gallus NP_990800.1, Xenopus laevis NP_001083514.1, Danio rerio NP_958446.1, Drosophila melanogaster AAF55979.3) using ClustalW. Overall, PKLR is well conserved with a minimum of 60% identity across the species examined. To quantify conservation, we used SIFT, which assesses conservation and the physical properties to assign scores where values o0.05 are predicted to affect protein function. A31V (median sequence conservation (MSC) ¼ 4.32; score ¼ 0.00), L272V (MSC ¼ 3.84; 0.00), E277K (MSC ¼ 3.84; 0.02), R449C (MSC ¼ 3.84; 0.03) and R486W (MSC ¼ 3.84; 0.00) were predicted to substantially affect function, while V269F (MSC ¼ 3.84, 0.21) and A295I (MSC ¼ 3.84, 0.57) may be tolerated.
Further analyses support that these substitutions are likely to reduce PK enzymatic activity. Notably, L272V, E277K and R486W have been reported in PK-deficient patients 2, 3 with R486W being the most common mutation associated with PK deficiency. 13 While A295I has not been previously associated with PK deficiency, a similar mutation (A295V) does cause clinical symptoms. 14 Additionally, V269F, L272V, E277K and A295I are clustered within a 25-residue segment of the A domain of the enzyme, which contains active site residues, while R449C and R486W map near the allosteric regulatory site (C domain). The large number and variety of PKLR mutations reported to cause PK deficiency suggest that the protein is highly sensitive to even small changes. Modest changes in protein folding/stability could have serious consequences for long-term erythrocyte function as mature cells lack the means to compensate by generating more protein.
A31V merits further comment as it appeared at high frequency (6.9%) in NA. This mutation lies in the erythrocyte-specific N-domain, affecting a residue highly conserved in mammals. This mutation is either fairly neutral, offers some advantage, or is in linkage disequilibrium with a polymorphism increasing fitness. Distinguishing these possibilities will require characterizing A31V enzymatic activity and testing its association with response to malaria in case-control studies.
Should all coding variants be loss-of-function alleles, the expected overall rate of PK deficiency would be B1/ 4203 births. Stratified by geography, NA had the highest rate with an 8.6% mutant allele frequency, followed by PAK (1.3%) and SS (1.25%). No mutants were detected in our SA, SEA or EUR datasets. Although our report is the first to determine mutant allele frequency by complete sequencing, other studies have estimated mutant allele frequencies between 0.4-6% by genotyping for common variants, with the highest mutation prevalence in Saudi Arabia (6%) and Hong Kong (3%). 13, [15] [16] [17] We applied neutrality tests in DnaSP 5.10 18 to determine whether selection has altered the expected pattern of genetic variability in PKLR. 19 Neutrality tests are based on the principle that the mutation rate is constant and synonymous substitutions will behave in a neutral fashion, whereas non-synonymous changes will be either highly beneficial or deleterious to fitness, and thus targets of evolutionary selection. 20 As up to two thirds of statistically significant non-neutrality observations can be influenced by demographic history, 19 we also generated 1000 coalescent simulations using the CoSi package (http://www.broad.mit.edu/~sfs/cosi) and Best-fit model described by Schaffner et al. 21 to determine empirical P-values (emp-P). This model takes into account migration history, bottleneck, agriculture history, recombination rate and mutation rate, which were optimized to fit well with empirical data of each population. Simulations were run on a sequence length of 1725 bp corresponding to the coding region of PKLR, and population sizes were matched with our experimental data. In PAK, Tajima's test suggested nonneutrality, specifically when examining the distribution of non-synonymous SNPs (D ¼ À1.37292, emp-P ¼ 0.156, D NS ¼ À1.78894, emp-P ¼ 0.035). Fu and Li's D* and F* also rejected neutrality for SS (D* ¼ À2.89519, F* ¼ À2.46698, emp-P ¼ 0.001) and PAK (D* ¼ À4.55934, F* ¼ À4.07077, emp-P ¼ 0.001). Both populations were significantly non-neutral when compared with chimpanzee using the MacDonald-Kreitman test (Po0.02).
Together, these observations are in agreement with the proposal that the PKLR gene has been under selective pressure in some of the populations examined, possibly mediated by the malarial parasite. 22 Supplementary Information accompanies the paper on Genes and Immunity website (http://www.nature.com/gene)
